(Q42468650)

1 November 2017

Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study (English)

1 reference

1 November 2017

1 reference

Lucas GA

1

1 reference

1 November 2017

Hoffmann O

series ordinal

2

1 reference

1 November 2017

Alster P

series ordinal

3

1 reference

1 November 2017

Wiesenfeld-Hallin Z

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

1 November 2017

1 reference

1 November 2017

821

1 reference

1 November 2017

1

1 reference

1 November 2017

79-86

1 reference

Environmental modulation of analgesic tolerance induced by morphine pellets

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

The role of CCK caerulein, and CCK antagonists in nociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Reversal of tolerance to morphine but no potentiation of morphine-induced analgesia by antiserum against cholecystokinin octapeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Primary sensory neurones and naloxone-precipitated morphine withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Does chronic nociceptive stimulation alter the development of morphine tolerance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Differential release of cholecystokinin by morphine in rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

TOLERANCE TO AND PHYSICAL DEPENDENCE ON MORPHINE IN RATS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

CCK 8 analgesia and hyperalgesia after intrathecal administration in the rat: Comparison with CCK-related peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Determination of codeine and metabolites in plasma and urine using ion-pair high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Excess release of substance P from the spinal cord of mice during morphine withdrawal and involvement of the enhancement of presynaptic Ca2+ entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

On the origin of striatal cholecystokinin release: studies with in vivo microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901068-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(99)01068-9

1 reference

1 November 2017

1 reference